PTEN hamartoma tumor syndrome
1 paper
- Animals1
Trial sponsors
2 trialsPhase 2/3106 people
1 trialPhase 25 people
Latest
The Journal of Pathology
Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development
Experiments in miceRapamycin